Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-23-103617
Filing Date
2023-04-17
Accepted
2023-04-17 16:02:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC14D9C d492996dsc14d9c.htm SC14D9C 18965
  Complete submission text file 0001193125-23-103617.txt   20637
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filed by) CIK: 0001692830 (see all company filings)

EIN.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Subject) CIK: 0001692830 (see all company filings)

EIN.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-91126 | Film No.: 23823960
SIC: 2834 Pharmaceutical Preparations